• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Patente
  4. Hyphenspezifische Faktoren aus Candida albicans
 
  • Details
Options
Patent
Title

Hyphenspezifische Faktoren aus Candida albicans

Other Title
Nucleotide chip for specific detection of the hyphal, virulent, form of Candida albicans, comprises a solid support carrying a nucleotide sequence for identifying and transcribing genes that encode hyphae-specific proteins.
Abstract
Die vorliegende Erfindung betrifft Verfahren und Mittel zur Gewinnung von diagnostisch nutzbaren und therapeutisch wirksamen Substanzen gegen Infektionskrankheiten.

; 

WO 200185989 A UPAB: 20020204 NOVELTY - A nucleotide chip (A1) comprises a solid support carrying a nucleotide sequence (I) for identifying and transcribing genes (II) that encode hyphae-specific proteins (III). DETAILED DESCRIPTION - A nucleotide chip (A1) comprises a solid support carrying a nucleotide sequence (I) for identifying and transcribing genes (II) that encode hyphae-specific proteins (III), where (I) is: (i) any of sequences of 900 (2 sequences), 501, 486 (S1)-(S4), 968 (S12), 456 (S13), 486 (S15) or 1080 (S17) base pairs; (ii) sequences that encode proteins (P) of sequences of 299 (2 sequences), 166, 161 (5)-(8), 151 (14), 161 (16) or 359 (18) amino acids; or (iii) sequences that can hybridize to (i) or (ii), their complements and fragments. All sequences are given in the specification. INDEPENDENT CLAIMS are also included for the following: (1) similar protein chip (A2) containing (P), sequences at least 80 % identical with them or their fragments; (2) similar antibody chip (A3) containing at least one antibody (Ab) specific for (P); (3) similar antibody chip (A4) containing at least one antibody (Ab') specific for Ab; (4) diagnostic composition containing (A1)-(A4); (5) diagnosing Candida-mediated diseases; and (6) screening or identifying therapeutic agents for treating Candida-mediated diseases. ACTIVITY - Fungicide. MECHANISM OF ACTION - Expression and/or activity of hyphae-specific proteins associated with virulence inhibitor. USE - (A), and related protein and antibody chips, are used: (i) for diagnosis of Candida-mediated diseases (local or systemic infections); and (ii) to screen for agents that inhibit expression of hyphae-specific proteins, potential therapeutic agents. ADVANTAGE - (I), or related proteins and antibodies, are specific for the hyphal (virulent) form of Candida albicans, so allow differentiation between virulent and avirulent strains.
Inventor(s)
Rupp, S.  
Johannes, F.  
Sohn, Kai  
Link to Espacenet
http://worldwide.espacenet.com/publicationDetails/biblio?DB=worldwide.espacenet.com&locale=en_EP&FT=D&CC=DE&NR=10023130A
Patent Number
2000-10023130
Publication Date
2001
Language
German
Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024